Subscribe to RSS
DOI: 10.1055/s-0029-1219399
Brønsted Acidic Ionic Liquid as an Efficient and Reusable Catalyst for Synthesis of 14-Aryl- or 14-Alkyl-14H-dibenzo[a,j]xanthenes under Solvent-Free Conditions
Publication History
Publication Date:
17 February 2010 (online)
Abstract
A mild and efficient method has been developed for the preparation of 14-aryl- or 14-alkyl-14H-dibenzo[a,j]xanthenes from one-pot condensation of aldehydes with 2-naphthol using catalytic amount of Brønsted acidic ionic liquid ([TEBSA][HSO4]) under thermal solvent-free conditions. Excellent yields, short reaction times, easy workup and reusability of the catalyst as well as solvent-free conditions are advantages of this procedure.
Keywords
[TEBSA][HSO4] - Brønsted acidic ionic liquid - xanthenes - solvent-free - one-pot
- 1
Hideo T. inventors; Jpn. Tokkyo Koho, JP 56005480. ; Chem. Abstr. 1981, 95, 80922b - 2
Lambert RW,Martin JA,Merrett JH,Parkes KEB, andThomas GJ. inventors; PCT Int. Appl., WO 9706178. ; Chem. Abstr. 1997, 126, 212377y - 3
Poupelin JP.Saint-Rut G.Foussard-Blanpin O.Narcisse G.Uchida-Ernouf G.Lacroix R. Eur. J. Med. Chem. 1978, 13: 67 - 4
Banerjee A.Mukherjee AK. Stain Technol. 1981, 56: 83 - 5
Menchen SM,Benson SC,Lam JYL,Zhen W,Sun D,Rosenblum BB,Khan SH, andTaing M. inventors; U. S. Patent, US 6583168. ; Chem. Abstr. 2003, 139, 54287f - 6
Sirkecioglu O.Talinli N.Akar A. J. Chem. Res., Synop. 1995, 502 - 7
Bekaert A.Andrieux J.Plat M. Tetrahedron Lett. 1992, 33: 2805 - 8
Ion RM.Frackowiak D.Planner A.Wiktorowicz K. Acta Biochim. Pol. 1998, 45: 833 - 9
Casiraghi G.Casnati G.Cornia M. Tetrahedron Lett. 1973, 679 - 10
Knight DW.Little PB. J. Chem. Soc., Perkin Trans. 1 2001, 1771 - 11
Sen RN.Sarkar NN. J. Am. Chem. Soc. 1925, 47: 1079 - 12
Papini P.Cimmarusti R. Gazz. Chim. Ital. 1947, 77: 142 - 13
Ota K.Kito T. Bull. Chem. Soc. Jpn. 1976, 49: 1167 - 14
Su W.Yang D.Jin C.Zhang B. Tetrahedron Lett. 2008, 49: 3391 - 15
Mahdavinia GH.Rostamizadeh S.Amani AM.Emdadi Z. Ultrason. Sonochem. 2009, 16: 7 - 16
Rajitha B.Sunil Kumar B.Thirupathi Reddy Y.Narsimha Reddy P.Sreenivasulu N. Tetrahedron Lett. 2005, 46: 8691 - 17
Ko S.Yao C.-F. Tetrahedron Lett. 2006, 47: 8827 - 18
Bigdeli MA.Heravi MM.Mahdavinia GH. J. Mol. Catal. A: Chem. 2007, 275: 25 - 19
Pasha MA.Jayashankara VP. Bioorg. Med. Chem. Lett. 2007, 17: 621 - 20
Bigdeli MA.Heravi MM.Mahdavinia GH. Catal. Commun. 2007, 8: 1595 - 21
Mirjalili BBF.Bamoniri A.Akbari A. Tetrahedron Lett. 2008, 49: 6454 - 22
Dabiri M.Baghbanzadeh M.Shakouri Nikcheh M.Arzroomchilar E. Bioorg. Med. Chem. Lett. 2008, 18: 436 - 23
Sahoo S.Joseph T.Halligudi SB. J. Mol. Catal. A: Chem. 2006, 244: 179 - 24
Forbes DC.Weaver KJ. J. Mol. Catal. A: Chem. 2004, 214: 129 - 25
Welton T. Chem. Rev. 1999, 99: 2071 - 26
Wasserscheid P.Keim W. Angew. Chem. Int. Ed. 2000, 39: 3773 - 27
Wilkes JS. J. Mol. Catal. A: Chem. 2004, 214: 11 - 28
Cole AC.Jensen JL.Ntai I.Tran KLT.Weaver KJ.Forbes DC.Davis JH. J. Am. Chem. Soc. 2002, 124: 5962 - 29
Gui J.Cong X.Liu D.Zhang X.Hu Z.Sun Z. Catal. Commun. 2004, 5: 473 - 30
Fang D.Shi Q.-R.Cheng J.Gong K.Liu Z.-L. Appl. Catal. A: Gen. 2008, 345: 158 - 31
Hajipour AR.Zarei A.Khazdooz L.Mirjalili BBF.Sheikhan N.Zahmatkesh S.Ruoho AE. Synthesis 2005, 3644 - 32
Hajipour AR.Mirjalili BBF.Zarei A.Khazdooz L.Ruoho AE. Tetrahedron Lett. 2004, 45: 6607 - 33
Zarei A.Hajipour AR.Khazdooz L. Dyes Pigments 2010, 85: 133
References and Notes
All reagents were purchased from Merck
and Aldrich and used without further purification. All yields refer
to isolated products after purification. [TEBSA][HSO4] was synthesized
according to reported procedure.²9 Products were
characterized by spectroscopy data (IR, ¹H NMR,
¹³C
NMR spectra) and melting point. ¹H NMR (300,
400 and 500 MHz) and ¹³C NMR (75, 100
and 125 MHz) spectra were run in DMSO-d
6 and
CDCl3 solvents relative to TMS (δ = 0.00
ppm). IR spectra were recorded on a Shimadzu 435 IR spectrophotometer
and performed using KBr pellets. All melting points were taken on
a Gallenkamp melting apparatus and are uncorrected.
Preparations of Brønsted Acidic Ionic
Liquid {
N
-(4-Sulfonic Acid) Butyl Triethyl Ammonium Hydrogen Sulfate
([TEBSA][HSO
4
])}: 1,4-Butane sultone
(10 mmol, 1.0 mL), triethylamine (10 mmol, 1.4 mL) and MeCN (5 mL)
were charged into a 100-mL round-bottom flask. Then, the mixture
was refluxed for 10 h. The white solid zwitterion was filtered and
washed with EtOAc to remove nonionic residues and dried in vacuum
(2 g, 85% yield). Then, a stoichiometric amount of concentrated
sulfuric acid (96%, 0.5 mL) was added dropwise to zwitterions
and the mixture was stirred for 6 h at 80 ˚C to produce
the Brønsted acidic ionic liquid. ¹H
NMR (400 MHz, DMSO-d
6): δ = 1.16
(br s, 9 H), 1.59-1.73 (m, 4 H), 2.53 (t, J = 7.6
Hz, 2 H), 3.09-3.25 (m, 8 H), 6.46 (s, 2 H). ¹³C
NMR (100 MHz, DMSO-d
6):
δ = 7.60,
20.27, 22.23, 50.67, 52.48, 56.15.
General
Procedure for the Preparation of 14-Aryl- or 14-Alkyl-14
H
-dibenzo[a,j]xanthenes:
A mixture of aldehyde (1 mmol), 2-naphthol (2 mmol) and [TEBSA][HSO4] (0.15 mmol)
was stirred at 120 ˚C in an oil bath. The completion of
the reaction was monitored with TLC (EtOAc-cyclo-hexane,
1:3). After the appropriate time (as shown in Table
[²]
), the mixture was cooled
to r.t. and H2O (10 mL) was added and the product was
filtered and then recrystallized from EtOAc. The products were characterized
by spectral data (IR, ¹H NMR and ¹³C
NMR) and comparison of their physical data with the literature data.
The spectral data of some synthesized compounds are given below.
Compound 3d: ¹H NMR (400 MHz,
DMSO-d
6): δ = 7.03
(s, 1 H), 7.11-7.21 (m, 2 H), 7.39-7.47 (m, 4
H), 7.55 (t, J = 8.0 Hz, 2 H),
7.65-7.69 (m, 1 H), 7.95 (t, J = 10.0
Hz, 4 H), 8.48 (d, J = 8.0 Hz,
2 H). ¹³C NMR (125 MHz, CDCl3): δ = 36.79, 112.77,
118.16, 124.26, 126.33, 126.95, 128.81, 129.19, 130.23, 131.34,
132.79, 138.40, 150.31. IR (KBr): 3057, 1622, 1598, 1515, 1463,
1429, 1404, 1353, 1252 cm-¹. HRMS: m/z [M + H+] calcd
for C27H16Cl2O: 427.0578; found:
426.8718.
Compound 3i: ¹H
NMR (500 MHz, CDCl3): δ = 3.82 (s,
3 H), 6.56 (s, 1 H), 7.47 (dt, J = 0.9,
7.9 Hz, 2 H), 7.55 (d, J = 8.9
Hz, 2 H), 7.61-7.67 (m, 4 H), 7.83-7.89 (m, 6
H), 8.38 (d, J = 8.5 Hz, 2 H). ¹³C
NMR (125 MHz, CDCl3): δ = 38.54, 52.36,
116.88, 118.45, 122.86, 124.82, 127.37, 128.74, 129.33, 129.65,
130.32, 131.48, 131.73, 149.12, 150.42, 167.05. IR (KBr): 3060,
2998, 2950, 1709, 1621, 1607, 1591, 1515, 1459, 1433, 1402, 1287,
1251, 1241, 1190, 1116 cm-¹. HRMS: m/z [M + H+] calcd
for C29H20O3: 417.1412; found:
417.1561.
Compound 3j: ¹H
NMR (300 MHz, CDCl3): δ = 3.59 (s,
3 H), 6.42 (s, 1 H), 6.48 (d, J = 8.2
Hz, 1 H), 7.04 (t, J = 8.4 Hz,
2 H), 7.13 (d, J = 7.5 Hz, 1
H), 7.37 (t, J = 7.2 Hz, 2 H), 7.44
(d, J = 9.0 Hz, 2 H), 7.55 (t, J = 7.6 Hz, 2 H), 7.71-7.82 (m,
4 H), 8.36 (d, J = 8.7 Hz, 2
H). ¹³C NMR (75 MHz, CDCl3): δ = 38.17,
55.23, 111.19, 115.16, 117.40, 118.23, 121.00, 122.94, 124.45, 127.00,
128.99, 129.07, 129.50, 131.27, 131.68, 145.01, 148.96, 159.97.
IR (KBr): 3070, 3015, 2961, 2934, 2899, 1603, 1593, 1581, 1514,
1486, 1457, 1431, 1401, 1271, 1252, 1241 cm-¹.
Compound 3l: ¹H NMR (500 MHz,
CDCl3): δ = 2.18 (s, 3 H), 6.51 (s,
1 H), 7.00 (d, J = 8.0 Hz, 2
H), 7.44-7.48 (m, 4 H), 7.53 (d, J = 8.9
Hz, 2 H), 7.63 (t, J = 8.3 Hz,
2 H), 7.83 (d, J = 8.9 Hz, 2
H), 7.87 (d, J = 8.0 Hz, 2 H),
8.45 (d, J = 8.5 Hz, 2 H). IR
(KBr): 3070, 3020, 2902, 1620, 1591, 1509, 1458, 1431, 1401, 1247
cm-¹.
Compound 3m: ¹H
NMR (500 MHz, CDCl3): δ = 0.88 (d,
J = 6.9 Hz, 6 H),
2.31-2.35 (m, 1 H), 5.50 (d, J = 3.8
Hz, 1 H), 7.47 (d, J = 8.8 Hz,
2 H), 7.50 (d, J = 7.1 Hz, 2
H), 7.65 (t, J = 7.0 Hz, 2 H),
7.83 (d, J = 8.8 Hz, 2 H), 7.92
(d, J = 8.1 Hz, 2 H), 8.35 (d, J = 8.5 Hz, 2 H). IR (KBr):
3068, 2959, 2925, 2876, 1631, 1620, 1590, 1516, 1457, 1434, 1398, 1251,
1237 cm-¹.